Ampio Pharmaceuticals (NYSE: AMPE) will experience a significant rise of 2,000% in its stock price as a result of a reverse stock split. Despite being a small-cap pharma stock, Ampio has seen a rare increase of 170% in its stock price over the past year. Ampio’s reverse stock split involves consolidating 20 shares into one new share, resulting in a 20-to-1 reverse stock split. Overall, Ampio Pharmaceuticals’ implementation of a reverse stock split is a strategic move to address its low stock price and maintain its NYSE listing. Sources:– Ampio Pharmaceuticals (AMPE) to Rise 2,000% at Open as 20-to-1 Reverse Split Takes Effect (Source: dhakatribune.com)– Ampio Pharmaceuticals Announces Effective Date of Reverse Stock Split (Source: prnewswire.com)

Source: Dhaka Tribune September 12, 2023 11:23 UTC